TransEnterix, Inc. (NYSE:TRXC)
TransEnterix Inc. designs, develops and manufactures medical-devices. It offers SPIDER(R) Surgical System, a laparoscopic surgical platform that allows intra-abdominal triangulation procedures to be performed with articulating instruments through a single site. The company is primarily focused on the development and commercialization of SurgiBot, a patient-side minimally invasive surgical robotic system. TransEnterix Inc., formerly known as SafeStitch Medical, Inc., is based in United States.
TransEnterix, Inc. (NYSE:TRXC)’s Financial Overview
TransEnterix, Inc. (NYSE) surged 11.51% yesterday to close its trading session at $3.39. The company has 1 year Price Target of $6.17. TransEnterix, Inc. has 52-Week high of $6.98 and 52-Week Low of $1.27. The stock touched its 52-Week High on 6.98 and 52-Week Low on 1.27. The stock traded with the volume of 7.55 Million shares yesterday. The firm shows the market capitalization of $704.07 Million.
TransEnterix, Inc. (NYSE) reported its last quarterly earnings on 6/29/2018 where the firm reported its Actual EPS of $-0.06/share against the analyst consensus estimate of $-0.06/share. The difference between the actual and expected EPS is $0 a share with a surprise factor of 0%.
The firm is trading with SMA20 of -11.35 Percent, SMA50 of -32.64 Percent and SMA200 of -3.2 percent. TransEnterix, Inc. has P/S value of 47.9 while its P/B value stands at 4.19. Similarly, the company has Return on Assets of -64.9 percent, Return on Equity of -94.7 percent and Return on Investment of -30.5 Percent. The company shows Gross Margin and Operating Margin of 27.3 percent and 0 percent respectively.
The Stock currently has Analyst’ mean Recommendation of 2.4 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 3 analysts offering 12-month price forecasts for Transenterix Inc have a median target of 6.00, with a high estimate of 6.50 and a low estimate of 6.00. The median estimate represents a +76.99% increase from the last price of 3.39.
TransEnterix, Inc. is expected* to report earnings on 11/08/2018 after market close. The report will be for the fiscal Quarter ending Sep 2018. According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.07. The reported EPS for the same quarter last year was $-0.09.
ICICI Bank Limited (NYSE:IBN)
ICICI Bank offers a wide range of banking products and services to corporate and retail customers through a variety of delivery channels.
ICICI Bank Limited (NYSE:IBN)’s Financial Outlook
The 47 analysts offering 12-month price forecasts for ICICI Bank Ltd have a median target of 10.55, with a high estimate of 12.52 and a low estimate of 6.39. The median estimate represents a +8.29% increase from the last price of 9.74.
ICICI Bank Limited is estimated to report earnings on 11/09/2018. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.05. The reported EPS for the same quarter last year was $0.1.
According to Zacks Investment Research, ICICI Bank Limited has a Consensus Recommendation of 1. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock surged 1.35% and closed its last trading session at $9.74. The company has the market capitalization of $31.48 Billion. The stock has 52-week high of $11.26 and 52-Week low of $7.61. The firm touched its 52-Week high on 11.26 and 52-Week low on 7.61. The company has volume of 7.53 Million shares. The company has a total of 3.23 Billion shares outstanding.
ICICI Bank Limited (NYSE) in the last quarter reported its actual EPS of $0.06/share where the analyst estimated EPS was $0.09/share. The difference between the actual and Estimated EPS is $-0.03. This shows a surprise factor of -33.3 percent.
The company has YTD performance of 0.1 percent. Beta for ICICI Bank Limited stands at 1.47 while its ATR (average true range) is 0.24. The company has Weekly Volatility of 1.72%% and Monthly Volatility of 2.24%%.
ICICI Bank Limited has distance from 20-day Simple Moving Average (SMA20) of 9.2%, Distance from 50-Day Simple Moving Average of 9.37 percent and Distance from 200-Day Simple Moving Average of 8.72%.
The Company currently has ROA (Return on Assets) of 0 percent, Return on Equity (ROE) of 0 Percent and Return on Investment (ROI) of 3% with Gross margin of 0 percent and Operating & Profit margin of 0% and 0% respectively.